Trial intelligence / Profile preview

Transvaginal vs Transabdominal Digoxin for Second-trimester Abortion

NCT02277249Completed

Sponsor
University of California, Los Angeles
Start
Oct 2012
Primary completion
Oct 2014
Modality
Orthosteric Ligands
01

Overview

Randomised, open-label trial of digoxin, sponsored by University of California, Los Angeles. Primary endpoint: Patient Discomfort With Digoxin Injection. Started Oct 2012; status: completed.

02

Drugs

digoxin

Beyond the preview

Go deeper on NCT02277249.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02277249.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call